Abstract
Stroke is a leading cause of disability worldwide with improved treatments leading to higher survival rates and a greater demand for post-stroke rehabilitation. Technological rehabilitation solutions show promise to meeting this growing need for therapy, but for maximum impact they must be accessible and affordable. Here we investigate the potential for REVIVE, a low-cost virtual reality (VR) stroke rehabilitation system, to meet these requirements. The software we developed operates on the standalone Meta Quest line of VR Head Mounted Displays which are wireless, low cost (<$300 USD for the base 3S model), and require no external hardware. Hand tracking and voice recognition enable accessible engagement for users with a range of physical and cognitive abilities. An animated coach in the virtual environment guides users through gamified exercises simulating activities of daily living and functional movements. We tested the system with 60 younger adults without disabilities in a simulated stroke rehabilitation session. Users reported minimal visually induced motion sickness and more positive attitudes towards the VR technology after the experience. Additionally, we provide a normative dataset for several REVIVE tasks to serve as a healthy baseline for future clinical applications. Our findings suggest that this affordable consumer-grade system, suitable for home or clinical use, has considerable potential to improve access to post-stroke rehabilitation services.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by ResearchNS under the New Health Investigator Grant program.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Research Ethics Board of Acadia University (Wolfville, NS, Canada) gave ethical approval for this work (REB File # 22-07).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos